Implant applicators

Patent metadata

Field	Value
Publication number	US-12285596-B2
Application number	US-201716330025-A
Country	US
Kind code	B2
Filing date	Sep 5, 2017
Priority date	Sep 2, 2016
Publication date	Apr 29, 2025
Grant date	Apr 29, 2025

Abstract

An intracameral injector needle having a substantially cylindrical body defining a longitudinal flow path therein, and having a proximal end, a distal end, an outer peripheral face and a bevel region. A first bevel of the bevel region has a first bevel angle with respect to the outer peripheral face. A second bevel of the bevel region extends from the first bevel to the proximal end. The second bevel includes a tip of the intracameral injector needle, and has a second bevel angle with respect to the outer peripheral face, where the second bevel angle is different from the first bevel angle, the first bevel and the second bevel defining a transition therebetween. The transition is at least one of: (1) longitudinally positioned between the tip of the intracameral injector needle and a location of a maximum width of the bevel region; and (2) vertically disposed at a position below 50% of a maximum height of the bevel region.

First claim

The invention claimed is:

1. An ophthalmic injector needle comprising:
a substantially cylindrical body defining a longitudinal flow path therein, the body including a first end, a second end, an outer peripheral face and a bevel region, the longitudinal flow path extending from the first end to the second end;
a first bevel of the bevel region having a first bevel angle with respect to the outer peripheral face and a primary bevel rotation angle with respect to a midline of a needle cross-section; and
a second bevel of the bevel region extending from the first bevel to the first end, the second bevel:
(1) including a tip of the ophthalmic injector needle,
(2) having a second bevel angle with respect to the outer peripheral face, the second bevel angle greater than the first bevel angle, and
(3) having a secondary bevel rotation angle with respect to the midline of the needle cross-section, that is different from the primary bevel rotation angle;

the first bevel and the second bevel defining a first transition and a second transition therebetween,
the bevel region having a tapered width, and
the first transition and the second transition longitudinally positioned between the tip of the ophthalmic injector needle and a location of a maximum width of the bevel region, and wherein a first length of the first bevel and a second length of the second bevel are configured based on a thickness of a biological membrane to prevent the first transition and the second transition from penetrating an outer layer of the biological membrane simultaneously as the tip penetrates an inner layer of the biological membrane when the ophthalmic injector needle is inserted through the biological membrane by having a ratio between the second length of the second bevel, as measured from the tip to the first transition and the second transition, and the first length of the first bevel, as measured from the first transition and the second transition to where the outer peripheral face and the bevel region meet, is between:
1:0.97 and 1:4.93.

2. The ophthalmic injector needle of claim 1 , wherein the first bevel angle with respect to the outer peripheral face is between about 7.5 degrees and about 11.5 degrees, the second bevel angle with respect to the outer peripheral face is between about 18 degrees and about 22 degrees, and the secondary bevel rotation angle with respect to the midline of the needle cross-section is between about 28 degrees and about 32 degrees.

3. The ophthalmic injector needle of claim 2 , wherein the first bevel angle with respect to the outer peripheral face is about 9.5 degrees, the second bevel angle with respect to the outer peripheral face is about 20 degrees, and the secondary bevel rotation angle with respect to the midline of the needle cross-section is about 30 degrees.

4. The ophthalmic injector needle of claim 1 , wherein the first bevel angle with respect to the outer peripheral face is between about 4 degrees and about 8 degrees, the second bevel angle with respect to the outer peripheral face is between about 11 degrees and about 15 degrees, and the secondary bevel rotation angle with respect to the midline of the needle cross-section is between about 33 degrees and about 37 degrees.

5. The ophthalmic injector needle of claim 1 , wherein the first bevel angle with respect to the outer peripheral face is about 6 degrees, the second bevel angle with respect to the outer peripheral face is about 13 degrees, and the secondary bevel rotation angle with respect to the midline of the needle cross-section is about 35 degrees.

6. An intraocular injection device, comprising the ophthalmic injector needle of claim 1 .

7. The intraocular injection device of claim 6 , further comprising:
a cap having a proximal end, a distal end, and a longitudinal axis, the cap including a bristle retainer at least partially disposed therewithin at the distal end thereof, the bristle retainer having a bristle at least partially disposed therewithin;
a needle hub at least partially disposed within the cap;
the ophthalmic injector needle disposed within a hub pocket of the needle hub;
an applicator connected to the needle hub; and
at least one implant disposed within the ophthalmic injector needle, the ophthalmic injector needle and the at least one implant substantially aligned with one another along the longitudinal axis of the cap.

8. A method of administering an implant to a patient, the method comprising:
providing an ophthalmic injection device, including a preloaded needle hub assembly and an applicator handle, the preloaded needle hub assembly including: the ophthalmic injector needle of claim 1 , an implant, and a bristle disposed within a bristle retainer;
applying force to the ophthalmic injector needle to penetrate a biological membrane; and
actuating the applicator handle such that the implant is linearly advanced through the ophthalmic injector needle.

9. The ophthalmic injector needle of claim 1 , wherein a ratio between a first force used to penetrate the biological membrane from the tip to the first transition and the second transition compared to a second force used to penetrate the biological membrane from the first transition and the second transition to where the outer peripheral face and the bevel region meet is between:
1:1.05 and 1:1.66.

10. The ophthalmic injector needle of claim 1 , wherein the biological membrane is an optical membrane and the first transition and the second transition are positioned less than 500 μm from the tip.

11. The ophthalmic injector needle of claim 1 , wherein the first length and the second length are configured such that the first transition and the second transition are positioned within the biological membrane when the tip reaches the inner layer of the biological membrane.

12. The ophthalmic injector needle of claim 1 , wherein the first length and the second length are configured such that the first transition and the second transition are positioned outside of the biological membrane when the tip reaches the inner layer of the biological membrane.

13. An ophthalmic injector needle comprising:
a first bevel of a bevel region having a first bevel angle with respect to an outer peripheral face; and
a second bevel of the bevel region extending from the first bevel, the second bevel:
(1) including a tip of the ophthalmic injector needle,
(2) having a second bevel angle with respect to the outer peripheral face, the second bevel angle different from the first bevel angle, and
(3) a secondary bevel rotation angle with respect to a midline of a needle cross-section,

the first bevel and the second bevel defining a first transition and a second transition therebetween,
the bevel region having a tapered height, and
the first transition and the second transition vertically disposed at a position below 50% of a maximum height of the bevel region, and wherein a first length of the first bevel and a second length of the second bevel are configured based on a thickness of a biological membrane to prevent the first transition and the second transition from penetrating an outer layer of the biological membrane simultaneously as the tip penetrates an inner layer of the biological membrane when the ophthalmic injector needle is inserted through the biological membrane,
wherein a ratio between the second length of the second bevel and the first length of the first bevel is between one of:
1:0.97 and 1:4.93;
1:1.24 and 1:3.09; and
1:0.66 and 1:1.84.

14. The ophthalmic injector needle of claim 13 , wherein the first bevel angle with respect to the outer peripheral face is between about

Assignees

• Envisia Therapeutics Inc
• Alcon Inc

Inventors

• Navratil Tomas
• Nadkarni Akshay Nitish
• Willard Gretchen
• Corson Andrew
• Walker Matthew

Classifications

• A61B5/150396

  Specific tip design, e.g. for improved penetration characteristics · CPC title

• A61F2/1691

  Packages or dispensers for intraocular lenses (for contact lenses A45C11/005) · CPC title

• A61F2/1662

  Instruments for inserting intraocular lenses into the eye · CPC title

• A61F2/16

  Intraocular lenses · CPC title

• A61M5/158

  Needles {for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body} · CPC title